Thanks to Interverbal and Stavros, who have done all the work.
from Stavros:
- Peltola H & Patja A, Leinikki P, Valle M, Davidkin I and Paunio M (1998) No evidence for measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14 year prospective study (Research letters) Lancet 351:1327-8
- Gillberg C & Heijbel H, (1998). MMR and autism [commentary]. Autism, The International Journal of Research and Practice; 2:423-424.
- Taylor B et al (1999) Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. The Lancet; 353: 2026-29.
- Kaye J et al (2001). Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. British Medical Journal 322 :460-3.
- Farrington P et al (2001). MMR and autism: Further evidence against a causal association Vaccine 19:3632-5 Volume 19, Issue 27, 14 June 2001, Pages 3632-3635
- Black C (2002) Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. British Medical Journal 325 :419-21.
- Taylor B et al (2002) Measles, mumps and rubella vaccination and bowel problems or development regression in children with autism: population study. British Medical Journal 324 : 393-396.
- Donald A & Muthu V (2002) No evidence that MMR vaccine is associated with autism or bowel disease. Clinical Evidence, 7:331-40
from Interverbal:
1. Bertrand, J., Mars, A., Boyle, C., Bove, F., Yeargin-Allsop, M., & Decoufle, P. (2001). Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics, 108, 1155-161.
2. Chakrabarti, S., & Fombonne, E. (2001). Pervasive developmental disorders in preschool children. Journal of the American Medical Association, 285,3093-3099.
3. Chakrabarti, S., Fombonne, E., (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. American Journal ofPsychiatry, 162(6), 1133-1141.
4. Fombonne, E. (2002). Prevalence of childhood disintegrative disorder (CDD). Autism 6, 2, 147-155.
5. Fombonne, E. (2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update. Journal of Autism and Developmental Disorders. 33, 365-382.
6. Fombonne, E. (2001). Is there an epidemic of autism? Pediatrics.Vol 107 (2), 411-412.
7. Gernsbacher, M.A., Dawson, M, & Goldsmith, H. H. (2005).Three reasons not to believe in an autism epidemic. Current directions in psychological science, 14 (2), 55-58.
8. Gallo C, Volkmar F. Diagnosis of autism. Trends Evidence-BasedNeuropsychiatry 2003;5(1):23– 8.
9. Honda, H., Shimizu, Y., Imai, M., & Nitto, Y. (2005). Cumulative incidence of childhood autism: a total population study of better accuracy and precision. Developmental Medicine And Child Neurology. 47(1), 10-8.
10. Jick H, Beach KJ, Kaye JA. Incidence of autism over time.Epidemiology. (2006). Epidemiology, 17(1), 120-121.
11. Laidler, J. (2005). US Department of Education data on "autism" are not reliable for tracking autism prevalence. Pediatrics, 116 (1), 120-124.
12. Mandall, D. S., Novak, M. M., Zubritsky, C. D. (2005). Factors associated with age of diagnosis among children with autism spectrum disorders. Pediatrics,Vol 116 (6), 1480-6.
13. Spitzer, R., Siegal, B.(1990). The DSM-III R field trial of pervasive developmental disorders. Journal of American Academy of Child and Adolescent Psychiatry. 29, 855–862.
14. Tidmarsh, L., Volkmar, F, R. (2003)Diagnosis and epidemiology of autism spectrum disorders. Canadian Journal of Psychiatry. 48, 517-525.
15. Yeargin-Allsopp, M., Rice, C., Karapurka, T., Doernberg, N., Boyle, C., Murphy, C. (2003). Prevalence of autism in a US metropolitan area. Journal of the American Medical Association, 289, 49-89.For the MMR:
16. Fombonne E. MMR and autistic enterocolitis: a consistent epidemiological failure to find an association. Mol Psychiatry 2003;8:133–4.
17. Honda Shimizu, Y., Rutter, M. (2005). No effect of MMR withdrawal on the incidence of autism: a total population study. Journal of Child Psychology and Psychiatry, vol 46 (6), 572-579.
18. Horton, R., (2004). A statement by the editors of the Lancet. Lancet, 363, 820-1
19. Kaye, J. A., del Melero-Montes, M., & Jick, H. (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BritishMedical Journal, 322, 460–463.
20. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, andothers. A population-based study of measles, mumps, and rubella vaccinationand autism. New Engl J Med 2002;347:1477–82.
21. Madsen KM. Measles, mumps and rubella vaccination and autism. N Engl J Med2003;348:951–4.
22. Murch, S., Anthony, A., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, P., Valentine, A., Davies, S., & Walker-Smith, J. (2004). Retraction of interpretation, 363, 750.
23. Roberts W, Harford M. Immunization and children at risk for autism. PaediatricChild Health 2002;7:623–32.
24. Spitzer W. Measles, mumps, and rubella vaccination and autism. N Engl J Med2003;348:951–4.
25. Stoto MA, Cleary SD, Foster VB . Epidemiologic studies of MMR vaccine andautism. Washington (DC): Institute of Medicine Immunization Safety ReviewCommittee; 2001.
26. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine; no epidemiological evidence for a causal association. Lancet, 353, 2026-2029.For Thimerosal:
27. Andrews, N., Miller, E., Grant, A., Stowe, J., Osborne, V., Taylor, B. (2004). Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics. 114(3), 584-591.
28.Meadows, M. (2004). IOM report: no link between vaccines and autism. FDA Consumer. 38(5), 38-9.2
9. Nelson K, Bauman M. Thimerosal and autism? Pediatrics 2003. 111, 674–679.
30. Parker, S, K., Schwartz, B., Todd, J., Pickering, L, K. (2004). Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 114(3), 793-804.
31. Singh, V, K., Hanson, J. (2006). Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal. Pediatric Allergy and Immunology. 17, 291–296.
32. Stehr-Green, P., Tull, P., Stellfeld, M., Mortenson, P., Simpson. (2003). Autism and thimerosal-containing vaccines lack of consistent evidence for an association. American Journal of Preventative Medicine. 25(2), 101-106.
33. Verstraeten T, Davis RL, DeStefano F, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics.2003; 112 :1039 –1048
34. Vertraeten, T. (2004). Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline. Pediatrics. 113(2), 932.
Michael E. Pichichero, Angela Gentile, Norberto Giglio, Veronica Umido, Thomas Clarkson, Elsa Cernichiari, Grazyna Zareba, Carlos Gotelli, Mariano Gotelli, Lihan Yan and John Treanor
Mercury Levels in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines
Pediatrics 2008;121;e208-e214 http://pediatrics.aappublications.org/cgi/reprint/121/2/e208.pdf
University of California - Davis - Health System (2008, February 12). Some Cases Of Autism May Be Traced To The Immune System Of Mothers During Pregnancy. ScienceDaily. Retrieved February 15, 2008, from http://www.sciencedaily.com /releases/2008/02/080211172535.htm
From David Gorski at Science-Based Medicine:
Schechter R and JK Grether (2008). Continuing Increases in Autism Reported to California’s Developmental Services System. Arch. Gen. Psychiatry 65: 19-24.
Shattuck P (2006). The Contribution of Diagnostic Substitution to the Growing Administrative Prevalence of Autism in US Special Education. Pediatrics 117:1028-1037.
Hviid A, M Stellfeld, J. Wohlfahrt, and M Melbye (2003). Association between thimerosal-containing vaccines and autism. JAMA 290:1763-1766.
Madsen KM, MB Lauritsen, CB Pedersen, P Thorsen, AM Plesner, PH Andersen, PB Mortensen (2003). Thimerosal and the Occurrence of Autism: Negative Ecological Evidence From Danish Population-Based Data. Pediatrics 112:604-6.
Fombonne E, R Zakarian, A Bennett, L Meng, D. McLean-Heywood (2006). Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations. Pediatrics 118:e139-50.
Thompson WW, C Price, B Goodson, DK Shay, P Benson, VL Hinrichsen, E Lewis, E Eriksen, P Ray, SM Marcy, J Dunn, LA Jackson, TA Lieu, S Black, G Stewart, ES Weintraub, RL Davis, F DeStefano; Vaccine Safety Datalink Team (2007). Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years. NEJM 357:1281-1292.
Parker SK, B Schwartz, J Todd, and LKPickering (2004). Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114:793-804.
Fombonne E (2008). Thimerosal disappears but autism remains. Arch. Gen. Psychiatry 65: 15-6.
CDC List of Studies (pdf), with results and findings and citations
article on recall bias specifically related to vaccines:
Murphy, D., Hotopf, M., Wessely, S. (2008). Multiple vaccinations, health, and recall bias within UK armed forces deployed to Iraq: cohort study. BMJ, 337(jun30 1), a220-a220. DOI: 10.1136/bmj.a220
div.blogMain p.newMeta2 a {display: block; float: left; margin-right: 24px; padding: 3px 0 3px 24px; background-position: 0 50% ! important; background-repeat: no-repeat;}
Info pages and statements:
CDC
IOM Report
AAP especially "Autism Facts for Parents" which states:
The higher number of ASD cases is NOT due to vaccines. At one time it was thought
that thimerosal, a mercury-based preservative in vaccines, could contribute to ASD.
However, studies have shown there is no link. Indeed, thimerosal was removed from
childhood vaccines by 2002, and the cases of ASD have still risen.
No comments:
Post a Comment